Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Alzheimer’s disease market to reach $17bn across 8MM by 2033

Summary by Clinical Trials Arena
Rates of diagnosis and treatment are low, so there is need for diagnostic tests and biomarkers for classification and assessment response.The post Alzheimer’s disease market to reach $17bn across 8MM by 2033 appeared first on Clinical Trials Arena.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Clinical Trials ArenaClinical Trials Arena

Alzheimer’s disease market to reach $17bn across 8MM by 2033

Rates of diagnosis and treatment are low, so there is need for diagnostic tests and biomarkers for classification and assessment response.The post Alzheimer’s disease market to reach $17bn across 8MM by 2033 appeared first on Clinical Trials Arena.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Clinical Trials Arena broke the news in on Wednesday, August 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal